Endocrine alopecia

This study tested whether adding the antibiotic rifampicin to the standard antiseptic povidone-iodine could improve wound healing and prevent infection after hair transplantation. 65 adults were randomly assigned to receive either the combination or the standard antiseptic alone.…

This study is testing whether combining platelet-rich plasma (PRP) with Botox injections works better than PRP alone for treating androgenetic alopecia (common pattern baldness). About 76 adults aged 18 to 60 with mild to moderate hair loss will receive either the combo treatment…

This study tests whether tiny particles from stem cells (exosomes) can safely help regrow hair in men with androgenic alopecia (male pattern baldness). The exosomes are delivered into the scalp using a microneedle device. The trial will enroll 18 men aged 18 to 60 with mild to mo…

This trial tests whether intradermal injections of exosomes—tiny particles that help cells communicate—can regrow hair in people with androgenetic alopecia (common pattern baldness) better than the standard topical minoxidil treatment. Forty participants will receive either exoso…

This clinical trial is testing whether a daily oral supplement called SesZen-Bio can improve hair thickness, density, and growth in people with mild to moderate androgenic alopecia (common pattern hair loss). About 72 adults aged 25 to 45 will be randomly assigned to one of three…

This Phase 3 study tested a topical solution called clascoterone in 703 men with mild to moderate male pattern baldness. Participants applied the solution or a placebo to their scalp twice daily for 6 months, and some continued for another 6 months. The goal was to see if clascot…

This study tested a special mineral-ionic formula called THERAVEX REGENERA in 20 adults with hair loss. The treatment was used during hair transplant procedures and as a scalp therapy to help hair follicles grow back. Researchers checked safety and measured changes in hair densit…

This study tested a new way to take minoxidil for male pattern baldness: a tablet placed under the tongue. 142 men with moderate to severe hair loss took either the minoxidil tablet or a placebo twice daily for 24 weeks. The goal was to see if this method increases hair count and…

This study tested whether injecting platelet-rich plasma (PRP) into the scalp, along with using minoxidil lotion, can improve hair growth in people with moderate to severe androgenetic alopecia (common baldness). Thirty participants were split into two groups: one received PRP in…

This study tested a new medication called CG2001 for male pattern baldness in Chinese men aged 18 to 65. The goal was to see if it helps regrow hair and is safe to use. The trial involved 110 participants and measured changes in hair count after 24 weeks.

This study tested whether a dietary supplement (capsules and drink) could reduce hair loss in 240 adults with androgenetic alopecia or chronic telogen effluvium. Participants took the supplement or a placebo daily for 6 months. Researchers measured hair density and asked about pr…

This study tested whether injecting a person's own concentrated platelets (PRP) into the scalp can improve hair growth in men with male pattern baldness. Two hundred one men received 3 to 5 sessions of PRP injections. The main goal was to see if hair loss grade improved based on …

This study tested a daily supplement called Olistic Next Women in 39 women aged 50-65 with early female pattern hair loss. Over 6 months, researchers measured changes in hair density and shedding. The goal was to see if the supplement could help control hair thinning without chan…

This Phase 3 trial tested a topical solution called clascoterone for male pattern hair loss. 762 men with mild to moderate balding applied the solution or a placebo twice daily for 6 months, followed by another 6 months for those who responded. The goal was to see if clascoterone…

This early-stage trial tested the safety of a new topical gel called AH-001 in 64 healthy volunteers and men with male pattern baldness. Participants received either a single dose or daily doses for a week of the gel or a placebo. The study focused on side effects and how the dru…

This study tested a gel called PP405 for male and female pattern baldness. 78 adults used the gel or a placebo for 28 days, then everyone could use the real gel for 3 more months. The main goals were to check safety and how the body processes the drug.

This phase 2 trial tested a new drug called TDM-105795 for male pattern baldness. 71 men with mild to moderate hair loss applied a solution to their scalp every day for 16 weeks. The study measured hair count and hair width to see if the treatment helped regrow hair.

This completed study tested a new hair growth serum called SesZen-Bio against a standard treatment (minoxidil 1%) and a placebo in 108 adults with mild to moderate androgenic alopecia (male or female pattern baldness). Participants applied the serum daily to their scalp for sever…

This trial compares three approaches for people dealing with hair fall and premature graying: a polyherbal hair oil, a minoxidil 5% hair serum, and a combination of both. About 99 healthy adults aged 18 to 55 with noticeable hair fall will apply their assigned product to the scal…

This study tests a fermented hair serum to see if it safely helps hair grow and improves scalp health in people with mild to moderate hair thinning. About 34 adults will use either the serum or a placebo for a set time. Researchers will measure changes in hair growth rate, densit…

This study tests a scalp elixir containing caffeine, panthenol, and growth factors on 60 healthy adults with hair thinning or baldness. Participants apply the product daily for 56 days, and researchers measure oil levels, hair density, thickness, length, and hair loss. The goal i…

This study tested a special shampoo for people with hair loss from telogen effluvium or early male/female pattern baldness. 40 adults used the shampoo for 3 months. The goal was to see if it improved hair length and thickness. The study is now complete.

This study tested whether applying a cosmetic ingredient called latanoprost acid to the scalp could improve hair growth in women aged 18-60 with female pattern hair loss or chronic telogen effluvium. Twenty-nine women used one of three strengths of the product daily for six month…